Related Experiment Videos
Is maintenance digoxin necessary in patients with sinus rhythm?
Lancet (London, England)
|March 17, 1979
Summary
Discontinuing digoxin is safe for most patients with sinus rhythm, especially those with low plasma levels. Successful discontinuation was achieved in 86% of patients, with lower levels indicating higher success rates.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Digoxin is a long-standing cardiac glycoside used for heart failure and arrhythmias.
- Assessing the necessity of long-term digoxin therapy is crucial for patient management.
Purpose of the Study:
- To evaluate the feasibility and safety of discontinuing long-term digoxin therapy in patients with sinus rhythm.
- To identify predictors of successful digoxin withdrawal.
Main Methods:
- A cohort of 56 patients on long-term digoxin with sinus rhythm had their medication discontinued.
- Plasma-digoxin concentrations were measured before withdrawal.
- Clinical status and development of arrhythmias or heart failure were monitored post-discontinuation.
Main Results:
- 86% of patients (48/56) successfully discontinued digoxin without clinical deterioration.
- Patients with pre-withdrawal plasma-digoxin levels < 0.8 ng/ml had a high success rate (33/34).
- Deterioration, primarily new-onset atrial fibrillation, occurred in 7 of 22 patients with levels between 0.8-2.0 ng/ml.
Conclusions:
- Digoxin discontinuation is feasible in a majority of patients with sinus rhythm.
- Lower baseline plasma-digoxin concentrations are associated with successful withdrawal.
- Monitoring for atrial fibrillation is essential upon digoxin discontinuation.